BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 20 Years Since First U.S. FDA Approval
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
Go back to BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 20 Years Since First U.S. FDA Approval
April 13, 2022 11:46 AM EDT
AbbVie (NYSE: ABBV) Defended at Wells Fargo. Analyst recommends buying the weakness.
...
More